Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Agilent Acquires Artificial Intelligence Technology to Enhance Lab Productivity
Life Sciences Times
-
February 17, 2022
0
Venture Capital
Classiq Announces $33M in New Funding, Accelerating Its Journey to Become the Leading Quantum Software Development Platform
Life Sciences Times
-
February 17, 2022
0
Venture Capital
Star Therapeutics emerges from stealth mode raising $100M in financing since inception to be an innovation engine for rare disease therapies
Life Sciences Times
-
February 16, 2022
0
Venture Capital
Saguaro Closes $1.1M Start-Up Funding to Offer New Drug Discovery Technologies That Help Fight Human Disease
Life Sciences Times
-
February 16, 2022
0
Venture Capital
c-LEcta Announces That It Has Reached Agreement to Be Acquired by Kerry Group
Life Sciences Times
-
February 15, 2022
0
Venture Capital
BASF Venture Capital and Orbia Ventures Invest in Israeli Biotech Company FortePhest
Life Sciences Times
-
February 10, 2022
0
Venture Capital
Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines
Life Sciences Times
-
February 10, 2022
0
Venture Capital
Seismic Therapeutic Launches with $101 Million Series A Financing to Usher in a New Era of Immunology Drug Development Integrating Machine Learning
Life Sciences Times
-
February 9, 2022
0
Venture Capital
Neurovascular Company Perfuze Raises €22.5m ($25m) Series A for New Stroke Treatment
Life Sciences Times
-
February 9, 2022
0
Venture Capital
BTR Raises $15 Million in Series A Round to Transform the Validation Process for Life Sciences Companies
Life Sciences Times
-
February 9, 2022
0
Venture Capital
Dalrada Corporation Enters Into a $3MM Convertible Debt Funding
Life Sciences Times
-
February 9, 2022
0
Venture Capital
Eurofins to Acquire Genetic Testing Service JSC and Enter the Clinical Genetic Testing Market in Vietnam
Life Sciences Times
-
February 9, 2022
0
1
...
84
85
86
...
115
Page 85 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026